Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience.
CONCLUSION: For the first time we demonstrate that OCP is an effective therapy for non-atypical EH and is associated with higher remission rate compared with oral progestin. Reproductive outcomes are reassuring and comparable between the two groups.
PMID: 30887764 [PubMed - in process]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Cancer & Oncology | Databases & Libraries | Infertility | Miscarriage | OBGYN | Ovaries | Pathology | Polycystic Ovary Syndrome | Pregnancy | Reproduction Medicine | Study | Women